SBA
DEAD

Serial Number

97022306

Owner

Element Biosciences, Inc.

Attorney

Samantha C. Markley

Filing Date

Sep 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SBA Trademark

Serial Number: 97022306

SBA is a trademark filed by Element Biosciences, Inc. on September 10, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Element Biosciences, Inc. (35 trademarks)

9880 Campus Point Drive, Suite 210
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

September 10, 2021

Registration Date

Not Registered

Published for Opposition

October 25, 2022

Goods & Services

Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings

Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices and analyzers, none of the forgoing for use in the veterinary field

Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers

Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes

Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use; none of the forgoing for use in the veterinary field

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 26, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 26, 2026 ABN6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 26, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 26, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 9, 2025 EXRA
SOU EXTENSION 5 GRANTED
Dec 9, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 9, 2025 AITU
SOU EXTENSION 5 FILED
Jun 17, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Dec 16, 2024 EX4G
SOU EXTENSION 4 FILED
Dec 16, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 16, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 14, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jun 14, 2024 EX3G
SOU EXTENSION 3 FILED
Jun 14, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 2, 2023 EXRA
SOU EXTENSION 2 GRANTED
Nov 30, 2023 EX2G
SOU EXTENSION 2 FILED
Nov 30, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 30, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 9, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 6, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 6, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 6, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 30, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 1, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 28, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 19, 2021 NWOS
NEW APPLICATION ENTERED
Sep 14, 2021 NWAP